Why use the Kinevia™ for full-body rehabilitation?
Kinevia Clinical Study
The Kinevia is a high quality, intelligent exercise therapy system for upper and lower limbs, featuring a wide range of exercise modes and benefits for the user.
The Study
The paraplegic center at the Ulm – RKU University and Rehabilitation Clinics carried out a clinical study for the Kinevia system. Click here to download the full study.
The Kinevia Clinical Study took place in the period from 9/12/2013 to 13/12/2013 in the practice rooms of the paraplegic center of the RKU. The observational study of clinical benefit took place for the “Kinevia” leg trainer and “Kinevia Duo”. The Kinevia leg trainer (part no. 8000) and Kinevia Duo (part no. 8200) were tested at the Ulm University Orthopedic Clinic, with 7 patients (5 male, 2 female). The patients were 22 to 77 years of age.
Training Sessions
The following training sessions were carried out as part of the study:
- a) 10 minutes of passive training. The number of revolutions for the passive mode was set from 10 – 40 rpm for every individual patient. The automatic change of direction of rotation was set to two minutes.
- b) Then 5 minutes of active training was set, whereby the level of resistance was set between 1(= low resistance) and 10 (= average resistance) while the patient’s pulse was being monitored.
- c) The response behavior of the spasm control function was set individually for each patient.
- d) The pedal radius was set individually for each patient.
The same is repeated for the upper and lower body.
The Results
Therapeutic efficacy, course of therapeutic application and treatment goals achieved the following results for the Kinevia Clinical Study:
- Increase in vigilance
- Increase in the blood supply to the trained muscles
- Stabilisation of circulatory behaviour
- Increase in general well-being
The use of the “Kinevia” movement coach is useful for types of paralysis or neuromuscular disorders with loss of function to arms/legs, e.g. as a result of high transverse lesions, multiple sclerosis, muscular dystrophy, consequences of brain injury or neuromuscular diseases with comparable damage.